
PDL acquires majority stake in Noden
Executive Summary
PDL BioPharma Inc. is acquiring a majority stake in Noden Pharma DAC, a private specialty pharmaceutical company based in Ireland, which was formed in March 2016 to acquire established prescription medicines across various therapeutic areas from global pharma players.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Partial Acquisition
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com